Safety Net early supply rule
Pharmaceutical Benefits Scheme - Safety Net early supply rule
The Pharmaceutical Benefits Scheme (PBS) Safety Net plays an important role in keeping medicines affordable. It is an effective way of helping to limit out-of-pocket expenses for people who need a large number of medicines.
Safety Net early supply rule - List of medicines
Pharmaceutical benefits to which the Safety Net early supply rule applies if supplied within 20 days of a previous supply of the same medicine or any brand of an equivalent medicine to the same person under ‘immediate supply’ provisions.
The legal basis for the list of medicines is the National Health (Pharmaceutical benefits – early supply) Instrument 2015 made under subsection 84AAA(2) of the National Health Act 1953.
The purpose of the list below is to provide an easy-to-use compilation of the PBS medicines to which the Safety Net early supply rule applies, including the currently-listed brands of those medicines.This version of the list is not a legal document and, in cases of discrepancy, the National Health (Pharmaceutical Benefits - early supply) Instrument will be the source document for specifying which medicines are subject to Safety Net early supply arrangements.
|Drug – active ingredient name||Drug form and strength||Brand name(s)||Listed maximum quantity||Listed maximum repeats||Interval Days|
|UMECLIDINIUM||umeclidinium 62.5 microgram/actuation inhalation: powder for, 30 actuations||Incruse Ellipta||1||5||20|
|UMECLIDINIUM + VILANTEROL||umeclidinium 62.5 microgram/actuation + vilanterol 25 microgram/actuation powder for inhalation, 30 actuations||Anoro Ellipta 62.5/25||1||5||20|
|UPADACITINIB||upadacitinib 15 mg modified release tablet, 28||Rinvoq||28||3||20|
|upadacitinib 15 mg modified release tablet, 28||Rinvoq||28||4||20|
|upadacitinib 15 mg modified release tablet, 28||Rinvoq||28||5||20|
|upadacitinib 30 mg modified release tablet, 28||Rinvoq||28||3||20|
|upadacitinib 30 mg modified release tablet, 28||Rinvoq||28||4||20|
|upadacitinib 30 mg modified release tablet, 28||Rinvoq||28||5||20|
|USTEKINUMAB||ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial||Stelara||1||0||20|
|ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial||Stelara||1||1||20|
|ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial||Stelara||1||2||20|
|ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial||Stelara||2||0||20|